GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™ is protected by 10 US and 2 Canadian issued patents, and 1 EPO patent. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 120 patients with recurrent brain tumors in a clinical trial at Barrow Neurological Institute (BNI) and observed significant clinical improvement.
Location: United States
Employees: 11-50
Total raised: $299.4M
Founded date: 2017
Investors 8
Funding Rounds 8
| Date | Series | Amount | Investors |
| 11.06.2026 | Series E | $100M | Medical Te... |
| 16.07.2025 | Series D | $53M | Medical Te... |
| 22.01.2025 | Series D | $37M | - |
| 20.09.2024 | - | $35M | Horizon Te... |
| 24.03.2023 | Series C | $45M | Medical Te... |
| 23.11.2020 | Series B | $16M | - |
| 21.10.2020 | - | $3.4M | - |
| 31.01.2019 | - | $10M | - |
Mentions in press and media 28
| Date | Title | Description |
| 25.06.2026 | Eckuity Capital Launches Fund II and Backs Automata Technologies | Eckuity Capital, a North American healthcare growth equity firm, today announced the first close of Eckuity Capital Fund II and the fund’s inaugural investment, leading the Series C of Automata Technologies alongside Danaher, a global scien... |
| 16.06.2026 | GT Medical Technologies Secures $100M to Revolutionize Brain Tumor Treatment | GT Medical Technologies secured $100 million in oversubscribed Series E funding. Viking Global Investors led the round. These funds will fuel aggressive commercial expansion and advance critical clinical trials. The company's innovative Gam... |
| 11.06.2026 | GT Medical Technologies Raises $100 Million Series E Financing To Advance Brain Tumor Treatment Platform | GT Medical Technologies announced the completion of an oversubscribed $100 million Series E financing round led by new investor Viking Global Investors, with participation from existing investors including MVM Partners, Gilde Healthcare, Ev... |
| 09.06.2026 | GT Medical Technologies Raises $100M Series E to Advance Brain Tumour Therapy | GT Medical Technologies Raises $100M to Scale Brain Tumour Innovation GT Medical Technologies has raised $100 million in Series E funding. Viking Global Investors led the round. Several existing investors also participated. The round was ov... |
| 09.06.2026 | GT Medical Technologies Raises $100M in Series E Funding | GT Medical Technologies, Inc., a Tampa, AZ-based medical device company dedicated to improving the lives of patients with brain tumors, raised $100M in Series E funding. The round was led by Viking Global Investors with participation from e... |
| 09.06.2026 | Rylo Raises $85M in New Funding | Rylo (pka Nagish), a Tel Aviv, Israel- and NYC-based provider of an AI-powered communication platform built for and with the Deaf and hard-of-hearing community, raised $85M in new funding. The round was led by General Catalyst’s Customer Va... |
| 16.07.2025 | GT Medical Technologies: Final Closing Of $53 Million Series D To Advance Brain Tumor Treatments | GT Medical Technologies, a medical device company dedicated to improving the lives of patients with brain tumors, has announced the successful completion of its oversubscribed $53 million Series D equity financing round. The final close of ... |
| 15.07.2025 | GT Medical Technologies Raises Additional $16M; Closes $53M Series D Equity Financing | GT Medical Technologies, Inc., a Tempe, AZ-based medical device company raised additional $16M in Series D funding. Backers included FemHealth Ventures and Warren Point Capital. The company intends to use the funds to drive the expansion of... |
| 24.01.2025 | GT Medical Technologies: Pioneering a New Era in Brain Tumor Treatment with $37 Million Series D Funding | In the ever-evolving landscape of medical technology, GT Medical Technologies stands out like a lighthouse in a storm. This Tempe, Arizona-based company has recently secured $37 million in Series D funding, a financial boost that promises t... |
| 22.01.2025 | GT Medical Technologies: $37 Million (Series D) Raised For Improving Lives Of Patients With Brain Tumors | GT Medical Technologies – a medical device company that aims to improve patients’ lives with brain tumors – announced that the company has completed the $37 million first close of a Series D funding round. The funding was led by Evidity Hea... |
Show more